| Paediatric formulations—Getting to the heart of the problem JF Standing, C Tuleu International journal of pharmaceutics 300 (1-2), 56-66, 2005 | 291 | 2005 |
| Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform … CC Butler, FDR Hobbs, OA Gbinigie, NM Rahman, G Hayward, ... The Lancet 401 (10373), 281-293, 2023 | 290 | 2023 |
| What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies R Picetti, H Shakur-Still, RL Medcalf, JF Standing, I Roberts Blood coagulation & fibrinolysis 30 (1), 1-10, 2019 | 142 | 2019 |
| Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine A Li, VM Yuen, S Goulay-Dufaÿ, Y Sheng, JF Standing, PCL Kwok, ... British journal of anaesthesia 120 (5), 960-968, 2018 | 133 | 2018 |
| Understanding and applying pharmacometric modelling and simulation in clinical practice and research JF Standing British journal of clinical pharmacology 83 (2), 247-254, 2017 | 112 | 2017 |
| Scaling clearance in paediatric pharmacokinetics: all models are wrong, which are useful? E Germovsek, CIS Barker, M Sharland, JF Standing British journal of clinical pharmacology 83 (4), 777-790, 2017 | 111 | 2017 |
| Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children PAJG De Cock, JF Standing, CIS Barker, A de Jaeger, E Dhont, M Carlier, ... Antimicrobial agents and chemotherapy 59 (11), 7027-7035, 2015 | 99 | 2015 |
| Pharmacokinetic studies in children: recommendations for practice and research CIS Barker, JF Standing, LE Kelly, LH Faught, AC Needham, MJ Rieder, ... Archives of disease in childhood 103 (7), 695-702, 2018 | 96 | 2018 |
| Pharmacokinetic–pharmacodynamic modeling in pediatric drug development, and the importance of standardized scaling of clearance E Germovsek, CIS Barker, M Sharland, JF Standing Clinical pharmacokinetics 58 (1), 39-52, 2019 | 75 | 2019 |
| Advanced methods for dose and regimen finding during drug development: summary of the EMA/EFPIA workshop on dose finding (London 4–5 December 2014) FT Musuamba, E Manolis, N Holford, SYA Cheung, LE Friberg, ... CPT: pharmacometrics & systems pharmacology 6 (7), 418-429, 2017 | 66 | 2017 |
| Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis S Hennig, JF Standing, CE Staatz, AH Thomson Clinical pharmacokinetics 52, 289-301, 2013 | 66 | 2013 |
| Pharmacokinetic–pharmacodynamic modeling of the hypotensive effect of remifentanil in infants undergoing cranioplasty JF Standing, GB Hammer, WJ Sam, DR Drover Pediatric Anesthesia 20 (1), 7-18, 2010 | 66 | 2010 |
| Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies E Germovsek, I Lutsar, K Kipper, MO Karlsson, T Planche, C Chazallon, ... Journal of Antimicrobial Chemotherapy 73 (7), 1908-1916, 2018 | 63 | 2018 |
| Effect of age on the performance of bispectral and entropy indices during sevoflurane pediatric anesthesia: a pharmacometric study A Sciusco, JF Standing, Y Sheng, P Raimondo, G Cinnella, M Dambrosio Pediatric Anesthesia 27 (4), 399-408, 2017 | 55 | 2017 |
| Short versus long infusion of meropenem in very-low-birth-weight neonates H Padari, T Metsvaht, LT Kõrgvee, E Germovsek, ML Ilmoja, K Kipper, ... Antimicrobial agents and chemotherapy 56 (9), 4760-4764, 2012 | 55 | 2012 |
| Development and evaluation of a gentamicin pharmacokinetic model that facilitates opportunistic gentamicin therapeutic drug monitoring in neonates and infants E Germovsek, A Kent, T Metsvaht, I Lutsar, N Klein, MA Turner, ... Antimicrobial agents and chemotherapy 60 (8), 4869-4877, 2016 | 54 | 2016 |
| A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma ÅM Johansson, N Hill, M Perisoglou, J Whelan, MO Karlsson, JF Standing Therapeutic drug monitoring 33 (6), 711-718, 2011 | 54 | 2011 |
| Poor formulation information in published pediatric drug trials JF Standing, ZF Khaki, ICK Wong Pediatrics 116 (4), e559-e562, 2005 | 50 | 2005 |
| Use of whole-genome sequencing of adenovirus in immunocompromised pediatric patients to identify nosocomial transmission and mixed-genotype infection CJ Houldcroft, S Roy, S Morfopoulou, BK Margetts, DP Depledge, ... The Journal of Infectious Diseases 218 (8), 1261-1271, 2018 | 49 | 2018 |
| Diclofenac pharmacokinetic meta‐analysis and dose recommendations for surgical pain in children aged 1–12 years JF Standing, D Tibboel, R Korpela, KT Olkkola Pediatric Anesthesia 21 (3), 316-324, 2011 | 48 | 2011 |
